Intrinsiqs

Is Gossamer Bio, Inc. overvalued?

Gossamer Bio, Inc. (GOSS) — key valuation metrics and fundamentals.

No verdict
Price
$0.17
Fair value
Current P/E
Normal P/E
Market cap
$84.3M
Dividend yield
Return on equity
Sector
Healthcare

See the full interactive analysis →

Fair value compares GOSS's current P/E to its own historical "normal" P/E (FAST Graphs-style). Updated 13 Aug 2026.